pm mfvt1
    • Main page
      • About journal
      • Articles. Working with contents
      • Editor-in-chief
      • Editorial Council
      • Editorial Board


      • For authors
      • Standards for formatting information
      • Reviewing
      • Politics editorial board
      • Ethics of journal publications


      • For advertisers
      • Subscription
      • About the Publishing House
      • Contact us
  • Using Cellex drug in patients with chronic ischemia of brain and moderate cognitive disorders

    Редактор | 2017, Drugs and equipment, Practical medicine 01 (17) Neurology | 1 марта, 2017

    B.A. ABUSUEVA1, M.A. EVZELMAN2, P.R. KAMCHATNOV3, Kh.Ya. UMAROVA4

    1Dagestan State Medical Academy, 1 Lenin Square, Makhachkala, Russian Federation, 367000

    2 Medical Institute of Orel State University, 25 Oktyabrskaya Str., Orel, Russian Federation, 302028

    3 Russian National Research Medical University named after N.I. Pirogov, 1 Ostrovityanova Str., Moscow, Russian Federation, 117997

    4Chechen State University, 32 Sheripov Str., Grozny, Russian Federation, 364093

    Abusueva B.A. ― Cand. Med. Sc., Associate Professor, Head of the Department of Nervous Diseases, Neurosurgery and Medical Genetics

    Evzelman M.A. ― D. Med. Sc., Professor of the Department of Psychiatry and Neurology

    Kamchatnov P.R. ― D. Med. Sc., Professor of the Department of Neurology, Neurosurgery and Medical Genetics

    Umarova Kh.Ya. ― D. Med. Sc., Professor of the Department of Hospital Therapy with courses Outpatient Therapy, Propedeutics in Internal Diseases, general treatment of patients

    Chronic ischemia of brain is a widely spread type of cerebral-vascular pathology, and its presence is connected with the increased risk of both the acute ischemic stroke and the lasting neurologic deficit, first of all, cognitive disorders. Correction of the factors of cardio-vascular risk can slow down the progress of vascular lesion of brain, while maintenance of cognitive functions requires other therapeutic approaches. The authors consider the possibilities of using the new Russian drug Cellex in patients with moderate cognitive disorders in chronic ischemia of brain.

    Key words: chronic ischemia of brain, moderate cognitive disorders, therapy, Cellex.

    Метки: 2017, B.A. ABUSUEVA, Cellex, chronic ischemia of brain, Kh.Ya. UMAROVA, M.A. EVZELMAN, moderate cognitive disorders, P.R. KAMCHATNOV, Practical medicine 01 (17) Neurology, therapy

    ‹ Clinical experience of accelerated crosslinking in patients with keratoconus Use of Glycine in complex therapy of patients with paranoica schizophrenia with non-suicidal autoagressive behaviour and sings of residual-organic lesion of the central nervous system ›
    • rus Версия на русском языке


      usa English version site


      Findloupe

      

    • PARTNERS

      пов  logonew
    «Для
    Practical medicine. Scientific and practical reviewed medical journal
    All rights reserved ©